Ajanta Pharma Q2 Results FY27: PAT Jumps 49.18% as Revenue Rises 32.53%, Revenue Rs 1,794.16 Cr, PAT Rs 388.14 Cr

Ajanta Pharma Ltd (AJANTPHARM) Q2 Results FY27 announced on 30 October 2026, covering the company's financial performance for the July to September quarter. The Ajanta Pharma Q2 Results FY27 show revenue of Rs 1,794.16 Cr and net profit of Rs 388.14 Cr, reported on a Consolidated basis. The results date of 30 October 2026 follows the board meeting and the exchange filing, and the consolidated results are the basis for every figure here.

This Ajanta Pharma Q2 Results article is a results analysis built on the filing, covering financial highlights, business drivers, outlook and risks. Univest readers can use it alongside the NSE and BSE listings for AJANTPHARM, and the Financial Highlights table follows next.

Click Here – Get Free Investment Predictions

Ajanta Pharma Q2 Results FY27: Financial Highlights

Metric	Q2 FY27 (Sep 26)	Q2 FY26 (Sep 25)	YoY Change
Revenue	Rs 1794.16 Cr	Rs 1353.73 Cr	+32.53% YoY
Operating Profit	Rs 547.56 Cr	Rs 327.83 Cr	+67.03% YoY
Net Profit (PAT)	Rs 388.14 Cr	Rs 260.19 Cr	+49.18% YoY

Source: company filing for Ajanta Pharma Q2 Results FY27, 30 October 2026. Figures in Rs Crore, Consolidated basis.

Key Takeaways from Ajanta Pharma Q2 Results: What Stands Out

• Revenue of Rs 1,794.16 Cr was up 32.53% YoY from Rs 1,353.73 Cr in the same quarter last year.
• Net profit of Rs 388.14 Cr rose 49.18% YoY, giving YoY growth of 49.18% on this line.
• Operating Profit of Rs 547.56 Cr was up 67.03% YoY from Rs 327.83 Cr in the same quarter last year.
• Ajanta Pharma Q2 Results FY27 were declared on a consolidated basis, so every figure here covers that basis alone.
• The performance analysis follows next and sets these YoY moves in order.

Ajanta Pharma Q2 Results FY27: Performance Analysis

Ajanta Pharma reported revenue of Rs 1,794.16 Cr and net profit of Rs 388.14 Cr for July to September 2026, which makes revenue up 32.53% and net profit up 49.18% YoY. These quarterly results compare with Rs 1,353.73 Cr in revenue and Rs 260.19 Cr in net profit in the same quarter last year. The Ajanta Pharma Q2 Results FY27 filing is the source for both comparisons.

Operating Profit of Rs 547.56 Cr compares with Rs 327.83 Cr a year earlier, a rise of 67.03%, which is faster than both revenue and net profit. Net profit of Rs 388.14 Cr compares with Rs 260.19 Cr. The Ajanta Pharma Q2 Results figures therefore show all three lines higher.

The consolidated figures also place Ajanta Pharma ahead of its own year-earlier base on every headline line, and Ajanta Pharma Q2 Results FY27 gives Univest readers a clean reference for the next quarter. Revenue has now risen four quarters in a row. That is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points to revenue of Rs 1,794.16 Cr, up 32.5% year on year. In these quarterly results the revenue line has also risen in each of the last 4 quarters, which Ajanta Pharma Q2 Results FY27 confirms as a continuing pattern.

Net Profit Growth – Net profit rose 49.2% year on year to Rs 388.14 Cr. Ajanta Pharma therefore grew net profit faster than revenue, a comparison that follows directly from the 32.5% revenue rise and the 49.2% profit rise.

Net Profit Margin – Net profit margin improved to 21.6% from 19.2% in the comparison quarter. The wider margin sits beside Operating Profit of Rs 547.56 Cr, which was Rs 327.83 Cr in the same quarter last year.

FY27 Outlook After Ajanta Pharma Q2 Results

FY27 full-year results for Ajanta Pharma will depend on the quarters still to be declared, and Ajanta Pharma Q2 Results FY27 sets a high first half-year base of Rs 1,794.16 Cr in revenue for this quarter alone. Net profit of Rs 388.14 Cr is the figure later quarters will be set against.

Disclosed sector conditions will shape how readers interpret that base. The Univest Screener carries AJANTPHARM with its consolidated numbers, so the Rs 388.14 Cr net profit can be compared with other declared results before the risks section.

Key Risks to Watch After Ajanta Pharma Q2 Results FY27

Rising Debt-to-Assets Ratio

Debt-to-assets rose from 0.00 in FY22 to 0.05 in FY26. After Ajanta Pharma Q2 Results FY27, readers can follow whether this ratio stays near 0.05 in later filings, since it has moved up from zero over four years.

Margin Comparison Base

Net profit margin stands at 21.6% against 19.2% a year earlier. With YoY growth of 49.18% in net profit now in the base, later quarters will be measured against a higher starting point.

Revenue Base for Later Quarters

Revenue of Rs 1,794.16 Cr is the latest of four consecutive quarterly increases. Readers can watch whether the next declared quarter extends that run or breaks it, using this figure as the reference.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Ajanta Pharma Q2 Results FY27 show consolidated revenue of Rs 1,794.16 Cr and net profit of Rs 388.14 Cr, both higher than a year earlier. These quarterly results make Ajanta Pharma a clear reference point, and Ajanta Pharma Q2 Results should be read alongside later filings. Investors should consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Ajanta Pharma Q2 Results FY27

What are Ajanta Pharma Q2 Results FY27?

Ans. Ajanta Pharma Q2 Results FY27 cover July to September 2026, declared on 30 October 2026, with revenue of Rs 1,794.16 Cr and net profit of Rs 388.14 Cr on a consolidated basis. See the Financial Highlights section.

What is the results date for Ajanta Pharma Q2 Results FY27?

Ans. Ajanta Pharma Q2 Results FY27 were declared on 30 October 2026, which is the results date for Ajanta Pharma. This matches the date in the Quick Answer box, and the opening section covers the same filing.

What revenue was reported in Ajanta Pharma Q2 Results FY27?

Ans. Ajanta Pharma reported revenue of Rs 1,794.16 Cr in Ajanta Pharma Q2 Results FY27, against Rs 1,353.73 Cr a year earlier. That is a YoY rise of 32.53%, which the Performance Analysis section explains.

What net profit was reported in Ajanta Pharma Q2 Results FY27?

Ans. Ajanta Pharma reported net profit of Rs 388.14 Cr in Ajanta Pharma Q2 Results FY27, against Rs 260.19 Cr a year earlier. Alongside this, the Key Takeaways section sets that net profit beside the revenue figure.

How much YoY growth did revenue show in Ajanta Pharma Q2 Results FY27?

Ans. Revenue showed YoY growth of 32.53%, moving from Rs 1,353.73 Cr to Rs 1,794.16 Cr. This YoY figure appears in the Financial Highlights table, compared with the net profit move of 49.18%.

Did net profit rise or fall in Ajanta Pharma Q2 Results?

Ans. Net profit rose in Ajanta Pharma Q2 Results, up 49.18% YoY to Rs 388.14 Cr from Rs 260.19 Cr. This means the profit line moved with revenue, as the Key Takeaways section shows.

What was the Operating Profit in Ajanta Pharma Q2 Results FY27?

Ans. Ajanta Pharma Q2 Results FY27 show Operating Profit of Rs 547.56 Cr, up 67.03% from Rs 327.83 Cr a year earlier. This is the fastest-moving line in the Financial Highlights table, ahead of revenue growth of 32.53%.

Are Ajanta Pharma Q2 Results consolidated results or standalone results?

Ans. Ajanta Pharma Q2 Results are consolidated results, because the filing was declared on a consolidated basis. So every figure in the Financial Highlights table covers that basis, and Ajanta Pharma consolidated numbers should not be mixed in.

What business factors shaped Ajanta Pharma Q2 Results FY27?

Ans. The business factors in Ajanta Pharma Q2 Results FY27 include revenue growth and net profit growth. Alongside this, the Key Business Factors section gives the exact figure for each one, along with a third factor.

What are the key risks after Ajanta Pharma Q2 Results FY27?

Ans. The risks after Ajanta Pharma Q2 Results FY27 include rising debt-to-assets ratio and margin comparison base. Alongside this, the Key Risks section explains each one, using the figures for Ajanta Pharma.

What is the outlook after Ajanta Pharma Q2 Results?

Ans. FY27 full-year performance for Ajanta Pharma will depend on the quarters still to be declared and on disclosed sector conditions. So the Outlook section uses Rs 388.14 Cr of net profit as the base.

Where can I find the complete Ajanta Pharma Q2 Results FY27 data?

Ans. The complete Ajanta Pharma Q2 Results FY27 data is in the Financial Highlights table and in the exchange filing dated 30 October 2026. Univest also lists Ajanta Pharma on its stock page, which sits alongside this results analysis.